These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 27404380)

  • 41. Risk-reducing salpingectomy with delayed oophorectomy in BRCA1/2 mutation carriers: patients' and professionals' perspectives.
    Arts-de Jong M; Harmsen MG; Hoogerbrugge N; Massuger LF; Hermens RP; de Hullu JA
    Gynecol Oncol; 2015 Feb; 136(2):305-10. PubMed ID: 25560807
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The tubal hypothesis of ovarian cancer: caution needed.
    Collins IM; Domchek SM; Huntsman DG; Mitchell G
    Lancet Oncol; 2011 Nov; 12(12):1089-91. PubMed ID: 21868285
    [No Abstract]   [Full Text] [Related]  

  • 43. The effect of personal medical history and family history of cancer on the uptake of risk-reducing salpingo-oophorectomy.
    van der Aa JE; Hoogendam JP; Butter ES; Ausems MG; Verheijen RH; Zweemer RP
    Fam Cancer; 2015 Dec; 14(4):539-44. PubMed ID: 26264902
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Comparing Coordinated Versus Sequential Salpingo-Oophorectomy for BRCA1 and BRCA2 Mutation Carriers With Breast Cancer.
    S Chapman J; Roddy E; Panighetti A; Hwang S; Crawford B; Powell B; Chen LM
    Clin Breast Cancer; 2016 Dec; 16(6):494-499. PubMed ID: 27495996
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Comparison of Clinical Features and Outcomes in Epithelial Ovarian Cancer according to Tumorigenicity in Patient-Derived Xenograft Models.
    Eoh KJ; Chung YS; Lee SH; Park SA; Kim HJ; Yang W; Lee IO; Lee JY; Cho H; Chay DB; Kim S; Kim SW; Kim JH; Kim YT; Nam EJ
    Cancer Res Treat; 2018 Jul; 50(3):956-963. PubMed ID: 29059719
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Management updates for women with a BRCA1 or BRCA2 mutation.
    Nusbaum R; Isaacs C
    Mol Diagn Ther; 2007; 11(3):133-44. PubMed ID: 17570734
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Age-specific ovarian cancer risks among women with a BRCA1 or BRCA2 mutation.
    Kotsopoulos J; Gronwald J; Karlan B; Rosen B; Huzarski T; Moller P; Lynch HT; Singer CF; Senter L; Neuhausen SL; Tung N; Eisen A; Foulkes WD; Ainsworth P; Sun P; Lubinski J; Narod SA;
    Gynecol Oncol; 2018 Jul; 150(1):85-91. PubMed ID: 29793803
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Veliparib Monotherapy to Patients With BRCA Germ Line Mutation and Platinum-Resistant or Partially Platinum-Sensitive Relapse of Epithelial Ovarian Cancer: A Phase I/II Study.
    Steffensen KD; Adimi P; Jakobsen A
    Int J Gynecol Cancer; 2017 Nov; 27(9):1842-1849. PubMed ID: 28763368
    [TBL] [Abstract][Full Text] [Related]  

  • 49. RE: Breast Cancer Risk After Salpingo-Oophorectomy in Healthy BRCA1/2 Mutation Carriers: Revisiting the Evidence for Risk Reduction.
    Chai X; Domchek S; Kauff N; Rebbeck T; Chen J
    J Natl Cancer Inst; 2015 Sep; 107(9):. PubMed ID: 26264690
    [No Abstract]   [Full Text] [Related]  

  • 50. [Problems raised by the gynaecologic management of women with BRCA 1 & 2 mutations.Gynécol Obstét Fertil 2003;31:370-377].
    Stoppa-Lyonnet D
    Gynecol Obstet Fertil; 2003 Oct; 31(10):888-9; author reply 889. PubMed ID: 14642951
    [No Abstract]   [Full Text] [Related]  

  • 51. Risk-reducing salpingo-oophorectomy: a meta-analysis on impact on ovarian cancer risk and all cause mortality in BRCA 1 and BRCA 2 mutation carriers.
    Marchetti C; De Felice F; Palaia I; Perniola G; Musella A; Musio D; Muzii L; Tombolini V; Panici PB
    BMC Womens Health; 2014 Dec; 14():150. PubMed ID: 25494812
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Risk-reducing salpingo-oophorectomy in BRCA1 and BRCA2 mutation carriers.
    Rhiem K; Foth D; Wappenschmidt B; Gevensleben H; Büttner R; Ulrich U; Schmutzler RK
    Arch Gynecol Obstet; 2011 Mar; 283(3):623-7. PubMed ID: 20428881
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Risk-reducing salpingo-oophorectomy in patients with germline mutations in BRCA1 or BRCA2.
    Kauff ND; Barakat RR
    J Clin Oncol; 2007 Jul; 25(20):2921-7. PubMed ID: 17617523
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Chemotherapy for Patients with BRCA1 and BRCA2-Mutated Ovarian Cancer: Same or Different?
    Tan DS; Kaye SB
    Am Soc Clin Oncol Educ Book; 2015; ():114-21. PubMed ID: 25993149
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Prophylactic oophorectomy in Ontario.
    Elit L; Rosen B; Goel V; McLaughlin J; Fung MK; Shime J; Narod S
    Fam Cancer; 2001; 1(3-4):143-8. PubMed ID: 14574170
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Homologous recombination deficiency and ovarian cancer.
    Ledermann JA; Drew Y; Kristeleit RS
    Eur J Cancer; 2016 Jun; 60():49-58. PubMed ID: 27065456
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Early epithelial lesions in prophylactic annexectomies in patients at high risk of ovarian cancer: Report of a series of 93 cases].
    Selmes G; Ferron G; Filleron T; Querleu D; Mery E
    Gynecol Obstet Fertil; 2015 Oct; 43(10):659-64. PubMed ID: 26433315
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Prophylactic salpingectomy or salpingo-oophorectomy as an ovarian cancer prevention?].
    Chene G; Lamblin G; Le Bail-Carval K; Chabert P; Golfier F; Dauplat J; Deligdisch L; Penault-Llorca F; Mellier G
    Presse Med; 2015 Mar; 44(3):317-23. PubMed ID: 25578546
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Prophylactic salpingo-oophorectomy in BRCA1 mutation carriers and postoperative incidence of peritoneal and breast cancers.
    Menkiszak J; Chudecka-Głaz A; Gronwald J; Cymbaluk-Płoska A; Celewicz A; Świniarska M; Wężowska M; Bedner R; Zielińska D; Tarnowska P; Jakubowicz J; Kojs Z
    J Ovarian Res; 2016 Feb; 9():11. PubMed ID: 26928677
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Surgical treatment in ovarian cancer prevention in carriers of the BRCA1/BRCA2 mutation].
    Synowiec A; Wcisło G; Bodnar L; Szczylik C
    Ginekol Pol; 2012 Jan; 83(1):51-6. PubMed ID: 22384640
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.